Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

May-June 2023; Volume 37,Issue 3

Reviews

  • Open Access
    Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies
    ERIKA GALIETTA, SILVIA STROLIN, SILVIA BISELLO, FRANCESCO CELLINI, LUIGI LOVATO, GLORIA RAVEGNINI, CRISTIAN MARTIGNANI, ALBERTO SPADOTTO, MILLY BUWENGE, SILVIA CAMMELLI, LIDIA STRIGARI, ALESSIO G. MORGANTI and ALESSANDRA ARCELLI
    In Vivo May 2023, 37 (3) 963-971; DOI: https://doi.org/10.21873/invivo.13170
  • Open Access
    Is Network Meta-analysis a Revolutionary Statistical Tool for Improving the Reliability of Clinical Trial Results? A Brief Overview and Emerging Issues Arising
    GEORGE BEIS and IOANNIS PAPASOTIRIOU
    In Vivo May 2023, 37 (3) 972-984; DOI: https://doi.org/10.21873/invivo.13171

Experimental Studies

  • Open Access
    Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations
    JINMING SONG, LYNN MOSCINSKI, ETHAN YANG, HAIPENG SHAO, MOHAMMAD HUSSAINI and HAILING ZHANG
    In Vivo May 2023, 37 (3) 985-993; DOI: https://doi.org/10.21873/invivo.13172
  • Open Access
    Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
    DIAMANTIS I. TSILIMIGRAS, KALLIOPI THANOPOULOU, MARIA SALAGIANNI, GERASIMOS SIASOS, EVANGELOS OIKONOMOU, DESPINA D. PERREA, NIKOLAOS NIRAKIS, KONSTANTINOS FILIS, KONSTANTINOS TSIOUFIS, DIMITRIOS TOUSOULIS and FRAGISKA SIGALA
    In Vivo May 2023, 37 (3) 994-1002; DOI: https://doi.org/10.21873/invivo.13173
  • Open Access
    Blueberry Stem Extract Prevents Lacrimal Hyposecretion in Non-obese Diabetic Mice via Activation of AMPK
    KENJIROU OGAWA, YUTA OHNO, AKANE TAGASHIRA, KARIN URATA, KEITARO SATOH, NARUKI FUJIMOTO, HIROKO SONODA, MASAHIRO IKEDA, TOSHIYUKI MATSUZAKI, KAZUO NISHIYAMA, HISATO KUNITAKE, YO GOTO and MASAO YAMASAKI
    In Vivo May 2023, 37 (3) 1003-1015; DOI: https://doi.org/10.21873/invivo.13174
  • Open Access
    Relative Biological Effectiveness Values of Spot-scanning Proton Beam Therapy at Shonan Kamakura General Hospital
    SHINTARO SHIBA, MASASHI YAMANAKA, KAZUKI MATSUMOTO, AKIHIRO YAMANO, TAKAHIRO SHIMO, SHUNSUKE SUZUKI, TAKAYUKI YAGIHASHI, KAZUNORI NITTA, TATSUYA OHNO, KOICHI TOKUUYE and MOTOKO OMURA
    In Vivo May 2023, 37 (3) 1016-1021; DOI: https://doi.org/10.21873/invivo.13175
  • Open Access
    In Vivo Metabolism of 1,5-Anhydro-d-fructose to 1,5-Anhydro-d-glucitol
    MOE IJIRI, KAZUHIRO YOSHINAGA, HIROAKI KAWAGUCHI, NAOTO MIYAZAKI, MAIKO KAWAGUCHI, YOSHIKAZU FUJIMOTO, TOMOHIDE MATSUO and IKURO MARUYAMA
    In Vivo May 2023, 37 (3) 1022-1027; DOI: https://doi.org/10.21873/invivo.13176
  • Open Access
    Accessing Apoptosis Induction and Metastasis Inhibition Effect of Magnolol on Triple Negative Breast Cancer In Vitro
    YU-CHING LI, CHUI-NA WONG, FEI-TING HSU, JIANN-HWA CHEN, CHUNG-CHI YANG, HENG-HAO LIU, WEI-LUNG CHEN and YUEH-SHAN WENG
    In Vivo May 2023, 37 (3) 1028-1036; DOI: https://doi.org/10.21873/invivo.13177
  • Open Access
    Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis
    HONG-YI CHIU, SHIH-CHANG TSAI, FUU-JEN TSAI, YU-HSIANG LO, CHING-CHANG CHENG, TING-YUAN LIU, SYUN-RONG JHAN, JAI-SING YANG and YU-JEN CHIU
    In Vivo May 2023, 37 (3) 1037-1046; DOI: https://doi.org/10.21873/invivo.13178
  • Open Access
    Ex Vivo Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency Ablation
    TORU ISHIKAWA, IORI HASEGAWA, HIROSHI HIROSAWA, TSUBASA HONMOU, NOBUYUKI SAKAI, TAKANORI IGARASHI, SHUN YAMAZAKI, TAKAMASA KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA
    In Vivo May 2023, 37 (3) 1047-1051; DOI: https://doi.org/10.21873/invivo.13179
  • Open Access
    Enhancement of Wound Healing Efficacy by Chitosan-based Hydrocolloid on Sprague Dawley Rats
    LINH THI THUY LE, NGUYEN NGAN GIANG, PHAM NGOC CHIEN, XUAN-TUNG TRINH, NGUYEN-VAN LONG, LE THI VAN ANH, PHAM THI NGA, XIN-RUI ZHANG, SUN-YOUNG NAM and CHAN-YEONG HEO
    In Vivo May 2023, 37 (3) 1052-1064; DOI: https://doi.org/10.21873/invivo.13180
  • Open Access
    Abnormal Hyperphosphorylation of Tau in Canine Immune-mediated Meningoencephalitis
    MINGYUN SON, YEON CHAE, SANGGU KIM, TAESIK YUN, YOONHOI KOO, DOHEE LEE, HAKHYUN KIM, MHAN-PYO YANG, BYEONG-TECK KANG and SOOCHONG KIM
    In Vivo May 2023, 37 (3) 1065-1076; DOI: https://doi.org/10.21873/invivo.13181
  • Open Access
    Flavokawain B Inhibits Growth of Cholangiocarcinoma Cells by Suppressing the Akt Pathway
    JUN HYUK SON, YOUNG HOON CHOI, SANG HYUB LEE, WOO HYUN PAIK, JI KON RYU and YONG-TAE KIM
    In Vivo May 2023, 37 (3) 1077-1084; DOI: https://doi.org/10.21873/invivo.13182
  • Open Access
    13-Oxo-9Z,11E-octadecadienoic Acid Down-regulates c-Myc and Attenuates Breast Cancer Cell Stemness
    YU-CHAN KO, HACK SUN CHOI, SU-LIM KIM and DONG-SUN LEE
    In Vivo May 2023, 37 (3) 1085-1092; DOI: https://doi.org/10.21873/invivo.13183
  • Open Access
    Bio-characteristics and Efficacy Analysis of Biodegradable Poly Dioxanone Dermal Filler in a Mouse Model and Humans
    SHU-YI ZHOU, SO MIN KANG, YEON JU GU, XIN RUI ZHANG, DONG KEON YON, BYUNG HO SHIN, JUNG RYUL HAM, WON KU LEE, JE GEUN JEONG, HAN JIN KWON and CHAN-YEONG HEO
    In Vivo May 2023, 37 (3) 1093-1102; DOI: https://doi.org/10.21873/invivo.13184
  • Open Access
    The Role of HIF1-related Genes and Non-coding RNAs Expression in Clear Cell Renal Cell Carcinoma
    STAMATIKI GRAMMATIKAKI, HECTOR KATIFELIS, KONSTANTINOS STRAVODIMOS, EMMANOUIL BAKOLAS, NIKOLAOS KAVANTZAS, DIMITRA GRIGORIADOU and MARIA GAZOULI
    In Vivo May 2023, 37 (3) 1103-1110; DOI: https://doi.org/10.21873/invivo.13185
  • Open Access
    A Pilot Study of the Association VDR Polymorphisms With Primary Hyperparathyroidism
    ANGELIKI CHORTI, CHAROULA ACHILLA, DESPOINA TSALKATIDOU, MOYSIS MOYSIDIS, ANGELIKI CHEVA, ANTHOULA CHATZIKYRIAKIDOU and THEODOSIOS PAPAVRAMIDIS
    In Vivo May 2023, 37 (3) 1111-1116; DOI: https://doi.org/10.21873/invivo.13186
  • Open Access
    Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients’ Treatment Responses
    ZIQIAN FANG, JIMMY JIANYUAN ZENG, YIMING YANG, FIONA RUGE, JANE LANE, RACHEL HARGEST and WEN G. JIANG
    In Vivo May 2023, 37 (3) 1117-1128; DOI: https://doi.org/10.21873/invivo.13187
  • Open Access
    Altered Arylamine N-acetyltransferase 1 and miR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study
    OSWALDO HERNANDEZ-GONZALEZ, ROSA DEL CARMEN MILAN-SEGOVIA, DANIEL ZAVALA-REYES, DINORA MARGARITA ALVARADO-ZAMARRIPA, JUAN JOSE ORTIZ-ZAMUDIO, LOURDES CECILIA CORREA-GONZALEZ, JUAN MANUEL VARGAS-MORALES, EDITH ELENA URESTI-RIVERA and DIANA PATRICIA PORTALES-PEREZ
    In Vivo May 2023, 37 (3) 1129-1144; DOI: https://doi.org/10.21873/invivo.13188
  • Open Access
    Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters
    HTET HTET MIN-OO, TIN MAY AUNG, MOLIN WONGWATTANAKUL, PORNSUDA MARAMING, TANAKORN PROUNGVITAYA and SIRIPORN PROUNGVITAYA
    In Vivo May 2023, 37 (3) 1145-1155; DOI: https://doi.org/10.21873/invivo.13189
  • Open Access
    The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer
    FERNANDA VILLARRUEL-MELQUIADES, ELIZABETH HERNANDEZ-GALLEGOS, CARMEN SOLANO-AGAMA, MARIA EUGENIA MENDOZA-GARRIDO and JAVIER CAMACHO
    In Vivo May 2023, 37 (3) 1156-1163; DOI: https://doi.org/10.21873/invivo.13190

Clinical Studies

  • Open Access
    Cutaneous Melanoma of the Lip: A SEER Analysis of Epidemiology and Survival Outcomes With Focus on Surgery and Other Treatment Options
    JUAN A. VISCARDI, MATTEO SCAMPA, SOLANGE N. WALZ, JEROME MARTINEAU, PIETRO G. DI SUMMA, SALVATORE GIORDANO, DANIEL F. KALBERMATTEN and CARLO M. ORANGES
    In Vivo May 2023, 37 (3) 1164-1172; DOI: https://doi.org/10.21873/invivo.13191
  • Open Access
    Gastric-type Endocervical Adenocarcinoma: Comprehensive Cytopathological Analysis and Comparison With Usual-type Endocervical Adenocarcinoma
    HAEYON CHO, SUJIN PARK and HYUN-SOO KIM
    In Vivo May 2023, 37 (3) 1173-1181; DOI: https://doi.org/10.21873/invivo.13192
  • Open Access
    Relationship Between Cardiovascular Events and Serum Lipid and Plasma Fatty Acid Profile in Maintenance Hemodialysis Patients With Diabetic Mellitus
    NORIO NAKAMURA, HIROSHI OSAWA, DAIKI NAGAWA, MASAMICHI NAKATA, IKUYO NARITA-KINJO, TAKESHI FUJITA, REIICHI MURAKAMI, MICHIKO SHIMADA, HIROFUMI TOMITA, CHIKAKO TSUTAYA, HISAO SAITO and TADASHI SUZUKI
    In Vivo May 2023, 37 (3) 1182-1185; DOI: https://doi.org/10.21873/invivo.13193
  • Open Access
    Evaluation of Image Quality of Overweight and Obese Patients in CT Using High Data Rate Detectors
    IDANA FELDMANE, CHRISTIAN GAMPP, DANIEL HAUSMANN, STYLIANOS MAVRIDIS, ANDRÉ EULER, LUKAS J. HEFERMEHL, FRIEDRICH KNOTH, RAHEL A. KUBIK-HUCH, ANTONIO NOCITO and TILO NIEMANN
    In Vivo May 2023, 37 (3) 1186-1191; DOI: https://doi.org/10.21873/invivo.13194
  • Open Access
    First RAND-36-Item Health Survey in Three-dimensional Laparoscopy Cholecystectomy: A Prospective Randomized Study
    MAARET ESKELINEN, ANNI REPO, IINA SAIMANEN, TUOMAS SELANDER, JARI KÄRKKÄINEN, PETRI JUVONEN, SAMULI ASPINEN, JUKKA PULKKINEN and MATTI ESKELINEN
    In Vivo May 2023, 37 (3) 1192-1197; DOI: https://doi.org/10.21873/invivo.13195
  • Open Access
    Pre-treatment Emotional Distress in Patients Irradiated for Malignant Glioma
    DIRK RADES, AHMED AL-SALOOL, NATHAN Y. YU, PETER TRILLENBERG, MATTEO M. BONSANTO and JAN LEPPERT
    In Vivo May 2023, 37 (3) 1198-1204; DOI: https://doi.org/10.21873/invivo.13196
  • Open Access
    Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer
    DIRK RADES, AHMED AL-SALOOL, NATHAN Y. YU and TOBIAS BARTSCHT
    In Vivo May 2023, 37 (3) 1205-1210; DOI: https://doi.org/10.21873/invivo.13197
  • Open Access
    Therapy Guidance by Vaginal Smears of Pregnant Women With Preterm Complications in Correlation With Maternal and Neonatal Outcome: A Retrospective Analysis
    STEFAN STEFANOVIC, EVA WERNER, MARLIS GERIGK, RALPH HORNUNG, UROS KARIC, CHRISTEL WEIß, BENJAMIN TUSCHY, SEBASTIAN BERLIT and MARC SÜTTERLIN
    In Vivo May 2023, 37 (3) 1211-1218; DOI: https://doi.org/10.21873/invivo.13169
  • Open Access
    Lacrimal Sac Tumors: A Single-institution Experience, Including New Insights
    TAKAHIRO WAKASAKI, RYUJI YASUMATSU, MIKA TANABE, HIROSHI YOSHIKAWA, RINA JIROMARU, KAZUKI HASHIMOTO, MIOKO MATSUO, AKIKO FUJIMURA and TAKASHI NAKAGAWA
    In Vivo May 2023, 37 (3) 1219-1225; DOI: https://doi.org/10.21873/invivo.13198
  • Open Access
    Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan
    NOBUYUKI YORIOKA, TADASHI NAMISAKI, AKIHIKO SHIBAMOTO, JUNYA SUZUKI, TAKAHIRO KUBO, SATOSHI IWAI, FUMIMASA TOMOOKA, MISAKO TANAKA, SOICHI TAKEDA, YUKI FUJIMOTO, MASAHIDE ENOMOTO, KOJI MUARATA, TAKASHI INOUE, YUKI TSUJI, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO, MASAHARU YAMAZAKI and HITOSHI YOSHIJI
    In Vivo May 2023, 37 (3) 1226-1235; DOI: https://doi.org/10.21873/invivo.13199
  • Open Access
    Efficacy of Ascorbic Acid, Thiamine, and Hydrocortisone Combination Therapy: Meta-analysis of Randomized Controlled Trials
    TAKAHIRO KATO, TOMOHIRO MIZUNO, MASANORI NAKANISHI, JEANNIE K. LEE, SHIGEKI YAMADA, NAOTAKE TSUBOI and KAZUO TAKAHASHI
    In Vivo May 2023, 37 (3) 1236-1245; DOI: https://doi.org/10.21873/invivo.13200
  • Open Access
    Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting Database
    JUNYA SATO, NARU YAMAMOTO, YUKA KAWAHARA, TADASHI SHIMIZU and MAYAKO UCHIDA
    In Vivo May 2023, 37 (3) 1246-1252; DOI: https://doi.org/10.21873/invivo.13201
  • Open Access
    Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer
    YUICHI HIROSHIMA, HITOSHI ISHIKAWA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, MASATOSHI NAKAMURA, TOSHIKI ISHIDA, KOICHI OGAWA, KATSUJI HISAKURA, MASASHI MIZUMOTO, TATSUYA ODA, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    In Vivo May 2023, 37 (3) 1253-1259; DOI: https://doi.org/10.21873/invivo.13202
  • Open Access
    The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease
    TAKAYUKI MANABE, KUNINORI IWAYAMA, MASAYUKI CHUMA, YOSHIKAZU TASAKI and SEIJI MATSUMOTO
    In Vivo May 2023, 37 (3) 1260-1265; DOI: https://doi.org/10.21873/invivo.13203
  • Open Access
    Sarcopenia and the Therapeutic Effects of Androgen Receptor-axis-targeted Therapies in Patients With Castration-resistant Prostate Cancer
    TASUKU HIROSHIGE, NAOYUKI OGASAWARA, HISAJI KUMAGAE, KOSUKE UEDA, KATSUAKI CHIKUI, KEI-ICHIRO UEMURA, KIYOAKI NISHIHARA, MAKOTO NAKIRI, MITSUNORI MATSUO, SHIGETAKA SUEKANE and TSUKASA IGAWA
    In Vivo May 2023, 37 (3) 1266-1274; DOI: https://doi.org/10.21873/invivo.13204
  • Open Access
    Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma
    MORIYASU YAMAUCHI, AKIMICHI MINESAKI, TOMOYA ISHIDA, YUKI SATO, SEIJI OKAMURA, HIROYUKI SHUTO, NARIYUKI TANAKA, ERIKO HATAYAMA, NATSUKO SHIBAMIYA and YUICHIRO KURATOMI
    In Vivo May 2023, 37 (3) 1275-1280; DOI: https://doi.org/10.21873/invivo.13205
  • Open Access
    Fibrinogen-to-lymphocyte Ratio Predicts the Outcomes of Hypopharyngeal Squamous Cell Carcinoma Treated With Definitive Radiotherapy
    KANAME SATO, HIROMITSU HATAKEYAMA, HANAKO OKADA, MASAKO KAWANO, KOHEI YOSHIDA, YAMATO OKI, TATSU KUWAHARA, KAZUTOMO NIWA, YASUHIRO ISONO and NOBUHIKO ORIDATE
    In Vivo May 2023, 37 (3) 1281-1289; DOI: https://doi.org/10.21873/invivo.13206
  • Open Access
    Prognostic Nutritional Index as a Predictor of Prognosis in Postoperative Patients With Gastric Cancer
    TETSUSHI ISHIGURO, TORU AOYAMA, MIHWA JU, KEISUKE KAZAMA, MOMOKO FUKUDA, HARUKA KANAI, SHO SAWAZAKI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, HARUHIKO CHO, KENTARO HARA, MASAKATSU NUMATA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENKI SEGAMI, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2023, 37 (3) 1290-1296; DOI: https://doi.org/10.21873/invivo.13207
  • Open Access
    Influence of Geriatric Nutritional Risk Index on Occurrence of Adverse Events and Duration of Treatment in Patients With Lymphoma Receiving R-CHOP Therapy
    KEN KIKUCHI, MOMOKA SAWADA, GENKI TAKEDA, TAIKI WATANABE, TAKAFUMI SOUMA and HIDEKI SATO
    In Vivo May 2023, 37 (3) 1297-1303; DOI: https://doi.org/10.21873/invivo.13208
  • Open Access
    Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma
    TOMOYUKI MAKINO, KOUJI IZUMI, HIROAKI IWAMOTO, SUGURU KADOMOTO, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    In Vivo May 2023, 37 (3) 1304-1311; DOI: https://doi.org/10.21873/invivo.13209
  • Open Access
    Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece
    VASILIKI RAPTI, MARIA-EFFROSYNI LIVANOU, ANASTASIOS KOLLIAS, TILEMACHOS KOUTOURATSAS, ORESTIS SAVRANAKIS, VISSARIA SAKKA, THOMAS NITSOTOLIS, ELENI KAKALOU, KALOMOIRA ATHANASIOU, KONSTANTINOS N. SYRIGOS and GARYFALLIA POULAKOU
    In Vivo May 2023, 37 (3) 1312-1317; DOI: https://doi.org/10.21873/invivo.13210
  • Open Access
    68Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value?
    PIETRO PEPE, LUDOVICA PEPE, MARIA TAMBURO, GIULIA MARLETTA, FRANCESCO SAVOCA, MICHELE PENNISI and FILIPPO FRAGGETTA
    In Vivo May 2023, 37 (3) 1318-1322; DOI: https://doi.org/10.21873/invivo.13211
  • Open Access
    Predictive Factors of Lower Urinary Tract Injuries and Spontaneous Voiding Failure After Pelvic Fractures
    TOMOYUKI KANEKO, KAZUKI YANAGIDA, KENTARO MATSUI, TAKETO KAWAI, YUKIO YAMADA, KEISUKE ISHII, TAKETO KUROZUMI, TAKASHI SUZUKI, YOSHINOBU WATANABE, HIROTAKA KAWANO, TETSUYA SAKAMOTO and TOHRU NAKAGAWA
    In Vivo May 2023, 37 (3) 1323-1327; DOI: https://doi.org/10.21873/invivo.13212
  • Open Access
    Survival Impact of Lingual Lymph Node Metastases in Tongue Cancer: An Analysis Regarding Anatomical Subsites
    KOHTARO EGUCHI and MASAMI SUZUKI
    In Vivo May 2023, 37 (3) 1328-1333; DOI: https://doi.org/10.21873/invivo.13213
  • Open Access
    Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing Dialysis
    AKIRA MIMA
    In Vivo May 2023, 37 (3) 1334-1338; DOI: https://doi.org/10.21873/invivo.13214
  • Open Access
    Induction Therapy With Cisplatin, 5-Fluorouracil, Leucovorin, and Paclitaxel in Patients With Head and Neck Cancer
    CARLOS EDUARDO COELHO DE SA, DANIEL DE IRACEMA GOMES CUBERO, RAFAEL EVERTON ASSUNCAO RIBEIRO DA COSTA, RENATO DI PARDO, FELIPE JOSE SILVA MELO CRUZ, CLÁUDIA VAZ DE MELO SETTE, ELIANA ARAUJO DA SILVA and AURO DEL GIGLIO
    In Vivo May 2023, 37 (3) 1339-1345; DOI: https://doi.org/10.21873/invivo.13215
  • Open Access
    Topical Prevention of Radiation Dermatitis in Breast Cancer Patients: A Network Meta-analysis of Randomized Controlled Trials
    YUNG-SHUO KAO, YAO-CHENG WU, MIN-YOU WU, PEI-LIN WU, LI-YU LU and CHENG-HSIEN HUNG
    In Vivo May 2023, 37 (3) 1346-1357; DOI: https://doi.org/10.21873/invivo.13216
  • Open Access
    Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer
    BEE-SONG CHANG, TAI-CHU PENG, KUN-HAN LUE, YI-FENG WU and CHUN-HOU HUANG
    In Vivo May 2023, 37 (3) 1358-1364; DOI: https://doi.org/10.21873/invivo.13217
  • Open Access
    Images Combined With Surgical Procedures and Pathological Identification to Distinguish a Reactive Histiocytosis With Organized Hematoma From a Malignant Peripheral Nerve Sheath Tumor
    CHUN-JEN CHANG, CHUN-CHUNG CHEN, DER-YANG CHO, DA-TIAN BAU and CHAO-HSUAN CHEN
    In Vivo May 2023, 37 (3) 1365-1372; DOI: https://doi.org/10.21873/invivo.13218
  • Open Access
    Kimura’s Disease Diagnosed in the Department of Orthopedic Surgery Treated With Wide Excision: Report of Two Cases
    SEI MORINAGA, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, YUTA TANIGUCHI, YOHEI ASANO, TAKAYUKI NOJIMA and HIROYUKI TSUCHIYA
    In Vivo May 2023, 37 (3) 1373-1378; DOI: https://doi.org/10.21873/invivo.13219
  • Open Access
    Chronic Maxillary Sinusitis Caused by an Aspergilloma in the Context of Inadequately Treated Type II Diabetes Mellitus
    FLORIAN DUDDE, FILIP BARBAREWICZ, ADRIAN ZU KNYPHAUSEN and KAI-OLAF HENKEL
    In Vivo May 2023, 37 (3) 1379-1383; DOI: https://doi.org/10.21873/invivo.13220
  • Open Access
    Identification of Cutibacterium modestum in Spondylitis by Metagenomics Analysis
    YAO-TING HUANG, MENG-YIN YANG, YAN-CHIAO MAO, DING-YU LEE, YU-LUN KUO, CHIEN-HAO TSENG, CHIA-WEI LIU, YUN-CHING FU and PO-YU LIU
    In Vivo May 2023, 37 (3) 1384-1388; DOI: https://doi.org/10.21873/invivo.13221
  • Open Access
    Slowly Progressive Bone Marrow Metastasis of Gastric Cancer Followed-up Without Treatment
    HIROTAKA SUTO, YUMIKO INUI and ATSUO OKAMURA
    In Vivo May 2023, 37 (3) 1389-1393; DOI: https://doi.org/10.21873/invivo.13222
  • Open Access
    Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report
    YUKI KOBARI, KAZUHIKO YOSHIDA, RYO MINODA, HIRONORI FUKUDA, KEISUKE HATA, KOHEI UNAGAMI, JUNPEI IIZUKA, HIDEKI ISHIDA, YOJI NAGASHIMA and TOSHIO TAKAGI
    In Vivo May 2023, 37 (3) 1394-1398; DOI: https://doi.org/10.21873/invivo.13223
Back to top
Previous

In this issue

In Vivo: 37 (3)
In Vivo
Vol. 37, Issue 3
May-June 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations
  • Enhancement of Wound Healing Efficacy by Chitosan-based Hydrocolloid on Sprague Dawley Rats
  • Relationship Between Cardiovascular Events and Serum Lipid and Plasma Fatty Acid Profile in Maintenance Hemodialysis Patients With Diabetic Mellitus
  • Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
  • Gastric-type Endocervical Adenocarcinoma: Comprehensive Cytopathological Analysis and Comparison With Usual-type Endocervical Adenocarcinoma
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
In Vivo

© 2023 In Vivo

Powered by HighWire